Lonza Group Ag EBITDA 2012-2024 | LZAGY

Lonza Group Ag annual and quarterly EBITDA history from 2012 to 2024. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
  • Lonza Group Ag EBITDA for the quarter ending December 31, 2024 was $0M, a 0% increase year-over-year.
  • Lonza Group Ag EBITDA for the twelve months ending December 31, 2024 was $0M, a 0% increase year-over-year.
  • Lonza Group Ag 2023 annual EBITDA was $1.229B, a 41.29% decline from 2022.
  • Lonza Group Ag 2022 annual EBITDA was $2.093B, a 49.54% increase from 2021.
  • Lonza Group Ag 2021 annual EBITDA was $1.399B, a 4.93% decline from 2020.
Lonza Group Ag Annual EBITDA
(Millions of US $)
2023 $1,229
2022 $2,093
2021 $1,399
2020 $1,472
2019 $1,526
2017 $1,152
2016 $805
2015 $445
2014 $790
2013 $607
2012 $682
2011 $608
Lonza Group Ag Quarterly EBITDA
(Millions of US $)
2024-12-31
2023-12-31
2023-06-30
2022-12-31
2022-06-30
2021-12-31
2021-06-30
2020-12-31
2020-06-30
2019-12-31
2019-06-30
2018-12-31
2018-06-30
2017-12-31
2017-06-30
2016-12-31
2016-06-30
2015-12-31
2015-06-30
2014-12-31
2014-06-30
2013-12-31
2013-06-30
2012-12-31
2012-06-30
2011-12-31
2011-06-30
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $49.666B $7.468B
Lonza Group AG operates as a supplier to the pharmaceutical, healthcare and life-science industries. The Company divides its activities into four divisions: Life Science Ingredients; Microbial Control; Custom Manufacturing, and Bioscience. The company's Life Science Ingredients segment produces nutrition ingredients for applications in nutrition (food, feed and pharmaceutical application) and chemical intermediates for the agricultural industry. The Microbial Control division focuses on five areas: hygiene, wood protection, water treatment, oil/gas applications, and industrial preservation and comprises products ranging from disinfectants to household cleaning products. The Custom Manufacturing division comprises products used in pharmaceuticals sector. The Bioscience division comprises bioscience products, including cell culture and molecular biology tools for research, tests for microbial detection, and media used in the production of therapeutics. Lonza Group AG is headquartered in Basel, Switzerland.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $229.693B 27.62
Boston Scientific (BSX) United States $152.679B 38.22
Stryker (SYK) United States $148.653B 31.08
EssilorLuxottica (ESLOY) France $131.422B 0.00
Medtronic (MDT) Ireland $115.326B 16.35
Haleon (HLN) United Kingdom $44.744B 25.54
ResMed (RMD) United States $37.302B 28.02
Agilent Technologies (A) United States $35.020B 22.83
GE HealthCare Technologies (GEHC) United States $34.401B 16.33
Terumo (TRUMY) Japan $24.607B 31.96
Koninklijke Philips (PHG) Netherlands $23.139B 16.24
Insulet (PODD) United States $20.361B 79.92
Zimmer Biomet Holdings (ZBH) United States $18.556B 11.92
Baxter (BAX) United States $14.728B 11.00
Smith & Nephew SNATS (SNN) United Kingdom $13.262B 0.00
Demant (WILYY) Denmark $8.971B 0.00
Sunny Optical Technology (SNPTF) China $8.561B 0.00
Bio-Rad Laboratories (BIO) United States $6.993B 24.33
Lantheus Holdings (LNTH) United States $5.626B 14.19
Perrigo (PRGO) Ireland $3.785B 9.59
Prestige Consumer Healthcare (PBH) United States $3.780B 16.89
Haemonetics (HAE) United States $3.628B 16.52
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Envista Holdings (NVST) United States $3.424B 28.45
ICU Medical (ICUI) United States $3.253B 23.99
QuidelOrtho (QDEL) United States $2.052B 14.11
LeMaitre Vascular (LMAT) United States $1.891B 42.26
AtriCure (ATRC) United States $1.521B 0.00
Acuren (TIC) United States $1.395B 0.00
Green Thumb Industries (GTBIF) United States $1.389B 31.24
Phibro Animal Health (PAHC) United States $1.248B 15.96
AdaptHealth (AHCO) United States $1.244B 12.63
Neogen (NEOG) United States $1.170B 14.97
BioLife Solutions (BLFS) United States $1.050B 0.00
InMode (INMD) Israel $0.930B 9.37
Curaleaf Holdings (CURLF) Canada $0.771B 0.00
Kestra Medical Technologies (KMTS) United States $0.766B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.695B 0.00
Owens & Minor (OMI) United States $0.627B 5.21
Evolus (EOLS) United States $0.611B 0.00
Tilray Brands (TLRY) Canada $0.584B 0.00
CeriBell (CBLL) United States $0.583B 0.00
Valneva SE (VALN) France $0.517B 0.00
Surmodics (SRDX) United States $0.441B 0.00
SNDL (SNDL) Canada $0.365B 0.00
Capricor Therapeutics (CAPR) United States $0.349B 0.00
VAREX IMAGING (VREX) United States $0.337B 12.38
Cresco Labs (CRLBF) United States $0.323B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.304B 0.00
Sanuwave Health (SNWV) United States $0.298B 0.00
Quanterix (QTRX) United States $0.294B 0.00
Cerus (CERS) United States $0.277B 0.00
Viemed Healthcare (VMD) United States $0.266B 22.47
Sanara MedTech (SMTI) United States $0.258B 0.00
Aurora Cannabis (ACB) Canada $0.252B 74.83
ZimVie (ZIMV) United States $0.251B 11.39
Verano Holdings (VRNOF) United States $0.235B 0.00
Brainsway (BWAY) Israel $0.233B 61.55
OraSure Technologies (OSUR) United States $0.232B 0.00
Biote (BTMD) United States $0.223B 6.28
Omeros (OMER) United States $0.214B 0.00
Canopy Growth (CGC) Canada $0.208B 0.00
Organigram Global (OGI) Canada $0.194B 0.00
High Tide (HITI) Canada $0.191B 0.00
TriSalus Life Sciences (TLSI) United States $0.185B 0.00
Utah Medical Products (UTMD) United States $0.183B 14.93
Vireo Growth (VREOF) United States $0.163B 0.00
Exagen (XGN) United States $0.149B 0.00
FitLife Brands (FTLF) United States $0.122B 0.00
TerrAscend (TSNDF) Canada $0.117B 0.00
MacroGenics (MGNX) United States $0.102B 0.00
Jin Medical (ZJYL) China $0.100B 0.00
Fonar (FONR) United States $0.098B 12.68
Jushi Holdings (JUSHF) United States $0.090B 0.00
Veru (VERU) United States $0.088B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.087B 0.00
Quipt Home Medical (QIPT) United States $0.081B 0.00
Apyx Medical (APYX) United States $0.079B 0.00
Agape ATP (ATPC) $0.074B 0.00
InterCure (INCR) Israel $0.071B 0.00
Zynex (ZYXI) United States $0.068B 0.00
Cytosorbents (CTSO) United States $0.066B 0.00
ImmuCell (ICCC) United States $0.059B 0.00
Rockwell Medical (RMTI) United States $0.039B 0.00
Modular Medical (MODD) United States $0.039B 0.00
Nephros (NEPH) United States $0.038B 51.43
United-Guardian (UG) United States $0.037B 12.89
Safety Shot (SHOT) United States $0.034B 0.00
Allurion Technologies (ALUR) United States $0.021B 0.00
Flora Growth (FLGC) United States $0.015B 0.00
INLIF (INLF) $0.015B 0.00
Meihua Medical Technologies (MHUA) China $0.015B 0.00
Trinity Biotech (TRIB) Ireland $0.014B 0.00
IM Cannabis (IMCC) Canada $0.012B 0.00
Senestech (SNES) United States $0.011B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
Innovative Eyewear (LUCY) United States $0.007B 0.00
Sharps Technology (STSS) United States $0.006B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00